Completed NA INTERVENTIONAL 2-arm NCT00287638

Markers in Exhaled Breath Condensate in Obstructive Sleep Apnoea (OSA) Patients

To Assess the Differences in Chemokines and Oxidative Stress Markers in Exhaled Breath Condensate of Obstructive Sleep Apnoea Patients

Sponsor: Chinese University of Hong Kong

Conditions Obstructive Sleep Apnea

Interventions CPAP placebo

Updated 5 times since 2017 Last updated: Jan 21, 2010 Started: Jan 31, 2006 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Obstructive Sleep Apnea, this trial is completed. The trial is conducted by Chinese University of Hong Kong and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shatin, Hong Kong